BlackRock Amends Ingevity Stake, Maintains Significant Holding
Ticker: NGVT · Form: SC 13G/A · Filed: 2024-01-22T00:00:00.000Z
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock still owns a chunk of Ingevity, good for stability.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 22, 2024, disclosing its ownership of Ingevity Corp. common stock as of December 31, 2023. This filing, an amendment number 2, indicates BlackRock continues to be a significant institutional holder in Ingevity, a company specializing in chemicals and allied products. For investors, this means a major institutional player maintains a substantial stake, often viewed as a sign of confidence, but any future reduction in their holdings could signal a shift in their outlook.
Why It Matters
Large institutional ownership by firms like BlackRock can provide stability to a stock, but changes in their position can influence market sentiment and price movements.
Risk Assessment
Risk Level: low — This filing simply updates BlackRock's passive ownership, indicating no immediate change in control or significant new risks for Ingevity Corp.
Analyst Insight
Investors should note BlackRock's continued presence as a major shareholder, but this filing itself doesn't suggest any immediate buy or sell action; it's a routine update of a passive stake.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Ingevity Corp. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 22, 2024 (date) — the filing date of the SC 13G/A amendment
- 45688C107 (other) — the CUSIP number for Ingevity Corp. Common Stock
Forward-Looking Statements
- BlackRock will maintain a significant, passive stake in Ingevity Corp. throughout 2024. (BlackRock Inc.) — medium confidence, target: 2024-12-31
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, specifically Amendment No: 2, as stated in the filing.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., as clearly identified under 'Names of reporting persons' on the cover page.
What is the subject company whose securities are being reported?
The subject company is INGEVITY CORPORATION, as stated under 'Name of Issuer' in the filing.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of Ingevity Corporation is 45688C107, as listed in the filing.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified in the document.
From the Filing
EDGAR Filing Documents for 0001086364-24-000758 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0001086364-24-000758 Filing Date 2024-01-22 Accepted 2024-01-22 14:03:06 Documents 1 Document Format Files Seq Description Document Type Size 1 us45688c1071_012224.txt SC 13G/A 11692 Complete submission text file 0001086364-24-000758.txt 13545 Mailing Address 50 HUDSON YARDS NEW YORK NY 10001 Business Address 50 HUDSON YARDS NEW YORK NY 10001 212-810-5300 BlackRock Inc. (Filed by) CIK : 0001364742 (see all company filings) EIN. : 320174431 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A SIC : 6211 Security Brokers, Dealers & Flotation Companies (CF Office: 02 Finance) Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300 Ingevity Corp (Subject) CIK : 0001653477 (see all company filings) EIN. : 474027764 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-89526 | Film No.: 24548117 SIC : 2800 Chemicals & Allied Products (CF Office: 08 Industrial Applications and Services)